Line 67: | Line 67: | ||
<h3> Fusing </h3> | <h3> Fusing </h3> | ||
<article> | <article> | ||
− | We explored the possibilities of a new method for highly specific protein terminus independent fusing based on the binding of 1,2‑aminothiols and the cyano group of cyanobenzothiazole (CBT). Therefore, we designed and synthetized a whole new amino acid by coupling the amino group of 6 amino-2-cyanobenzothiazole and the carboxyl group of the side chain of aspartic acid. The result was Nγ 2 cyanobenzothiazol 6 yl L asparagine (CBT-Asp). As counterpart, we used Nε-L-cysteinyl-L-lysine (CL), which contains the 1,2-aminothiol group. This way, we created a pair of non-canonical amino acids which residues can bind covalently to each other under physiological conditions. We cloned the aaRS for CL in pSB1C3 and predicted | + | We explored the possibilities of a new method for highly specific protein terminus independent fusing based on the binding of 1,2‑aminothiols and the cyano group of cyanobenzothiazole (CBT). Therefore, we designed and synthetized a whole new amino acid by coupling the amino group of 6 amino-2-cyanobenzothiazole and the carboxyl group of the side chain of aspartic acid. The result was Nγ 2 cyanobenzothiazol 6 yl L asparagine (CBT-Asp). As counterpart, we used Nε-L-cysteinyl-L-lysine (CL), which contains the 1,2-aminothiol group. This way, we created a pair of non-canonical amino acids which residues can bind covalently to each other under physiological conditions. We cloned the aaRS for CL in pSB1C3 and predicted 12 possible sequences of an aaRS able to incorporate the new amino acid CBT Asp by modeling. |
</article> | </article> | ||
</div> | </div> |
Revision as of 10:40, 4 October 2017
Toolbox Overview